Faster, cheaper hypersonic missiles: Ex-SpaceX team gets funding boost
Castelion’s Series A funding round raised $100 million, led by Lightspeed Venture Partners and including several other firms.
Related Articles
New York doctor indicted for prescribing abortion pill in Louisiana
A New York doctor has been indicted by a Lousiana grand jury for allegedly prescribing an abortion pill online in the Deep South state, which…
Up and down the ladder: The latest comings and goings
From new hires to departures, promotions and transfers, here are the latest comings and goings in the pharmaceutical industry.
Mizuno USA says hackers stayed in its network for two months
Mizuno USA, a subsidiary of Mizuno Corporation, one of the world’s largest sporting goods manufacturers, confirmed in data breach notification letters that unknown attackers stole…
Top digital health funding: Radiology AI company gets $60M
Rad AI has developed generative AI software that provides automated reporting tools to radiologists.
Cancer is meeting its match at every turn
Scientists and clinicians are taking a page from cancer’s playbook, learning to be just as canny, expansive and relentless in efforts to beat the disease.
DeepSeek’s Safety Guardrails Failed Every Test Researchers Threw at Its AI Chatbot
Security researchers tested 50 well-known jailbreaks against DeepSeek’s popular new AI chatbot. It didn’t stop a single one.
Leaving the W.H.O. Could Hurt Americans on a Range of Health Matters
President Trump’s decision to pull out of the international health agency could deprive the United States of crucial scientific data and lessen the country’s influence…
Alcohol and Cancer Risk: The Sobering Facts
Can alcohol increase your cancer risk? Learn the sobering truth to this question.
WHO and partners enable access to candidate vaccine and treatments for outbreak of Sudan Ebola virus disease in Uganda
WHO and partners have immediately boosted their support to the Ugandan government’s response to an outbreak of Sudan virus disease outbreak (SVD, part of the…
RFK Jr. says U.S. won’t threaten pharmaceutical patents to push for lower drug prices
The use of march-in rights to target pricy drugs has been a controversial issue across several administrations.